This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.Need a new registration confirmation email? Click here

Aetna Inc (AET): Today's Featured Health Services Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Aetna (
AET) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.6%. By the end of trading, Aetna fell $0.81 (-1.3%) to $63.24 on light volume. Throughout the day, 1,805,565 shares of Aetna exchanged hands as compared to its average daily volume of 2,837,300 shares. The stock ranged in price between $63.13-$63.98 after having opened the day at $63.88 as compared to the previous trading day's close of $64.05. Other companies within the Health Services industry that declined today were:
Biolase (
BIOL), down 33.7%,
Spherix (
SPEX), down 19.1%,
IMRIS (
IMRS), down 15.9% and
Bovie Medical Corporation (
BVX), down 10.7%.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $23.6 billion and is part of the health care sector. Shares are up 38.3% year to date as of the close of trading on Tuesday. Currently there are 11 analysts that rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates
Aetna as a
buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, increase in net income, attractive valuation levels and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.